Sexually Transmitted Diseases Treatment Guidelines 2002

Total Page:16

File Type:pdf, Size:1020Kb

Sexually Transmitted Diseases Treatment Guidelines 2002 Morbidity and Mortality Weekly Report Recommendations and Reports May 10, 2002 / Vol. 51 / No. RR-6 Sexually Transmitted Diseases Treatment Guidelines 2002 Centers for Disease Control and Prevention SAFER • HEALTHIER • PEOPLETM MMWR CONTENTS Introduction ..................................................................................................... 1 Clinical Prevention Guidelines .......................................................................... 2 The MMWR series of publications is published by the Prevention Messages .................................................................................... 2 Prevention Methods ...................................................................................... 3 Epidemiology Program Office, Centers for Disease STD/HIV Prevention Counseling .................................................................... 4 Control and Prevention (CDC), U.S. Department of Partner Notification ...................................................................................... 4 Reporting and Confidentiality ....................................................................... 4 Health and Human Services, Atlanta, GA 30333. Special Populations .......................................................................................... 5 Pregnant Women ......................................................................................... 5 Adolescents .................................................................................................. 6 Children ....................................................................................................... 7 Men Who Have Sex with Men ....................................................................... 7 HIV Infection: Detection, Counseling, and Referral ........................................... 7 Detection of HIV Infection: Diagnostic Testing ............................................... 8 SUGGESTED CITATION Counseling for Patients with HIV Infection and Referral to Support Services ... 9 Management of Sex Partners and Injection-Drug Partners ........................... 10 Centers for Disease Control and Prevention. Sexually Special Considerations ............................................................................... 10 Diseases Characterized by Genital Ulcers ....................................................... 11 transmitted diseases treatment guidelines 2002. Management of Patients Who Have Genital Ulcers ..................................... 11 MMWR 2002;51(No. RR-6):[inclusive page Chancroid .................................................................................................. 11 Genital Herpes Simplex Virus Infections ...................................................... 12 numbers]. Granuloma Inguinale (Donovanosis) .......................................................... 17 Lymphogranuloma Venereum ..................................................................... 18 Syphilis ...................................................................................................... 18 Congenital Syphilis ........................................................................................ 26 Evaluation and Treatment of Infants in the First Month of Life ..................... 26 Evaluation and Treatment of Older Infants and Children ............................. 28 Follow-Up .................................................................................................. 28 Special Considerations ............................................................................... 28 Centers for Disease Control and Prevention Management of Patients Who Have a History of Penicillin Allergy ................... 28 Recommendations ...................................................................................... 29 David W. Fleming, M.D. Penicillin Allergy Skin Testing ...................................................................... 29 Diseases Characterized by Urethritis and Cervicitis ......................................... 30 Acting Director Management of Male Patients Who Have Urethritis .................................... 30 Etiology ...................................................................................................... 30 Confirmed Urethritis ................................................................................... 30 Julie L. Gerberding, M.D. Management of Patients Who Have Nongonococcal Urethritis .................... 31 Acting Deputy Director for Science and Public Health Management of Patients Who Have Mucopurulent Cervicitis (MPC) ............. 32 Chlamydial Infections ................................................................................. 32 Gonococcal Infections ................................................................................ 36 Dixie E. Snider, Jr., M.D., M.P.H. Diseases Characterized by Vaginal Discharge ................................................. 42 Management of Patients Who Have Vaginal Infections ................................ 42 Associate Director for Science Bacterial Vaginosis ..................................................................................... 42 Trichomoniasis ........................................................................................... 44 Epidemiology Program Office Vulvovaginal Candidiasis ............................................................................ 45 Pelvic Inflammatory Disease ........................................................................... 48 Stephen B. Thacker, M.D., M.Sc. Diagnostic Considerations .......................................................................... 48 Treatment .................................................................................................. 49 Director Follow-Up .................................................................................................. 51 Management of Sex Partners ...................................................................... 51 Prevention .................................................................................................. 51 Office of Scientific and Health Communications Special Considerations ............................................................................... 51 Epididymitis ................................................................................................... 52 John W. Ward, M.D. Diagnostic Considerations .......................................................................... 52 Treatment .................................................................................................. 52 Director Follow-Up .................................................................................................. 53 Editor, MMWR Series Management of Sex Partners ...................................................................... 53 Special Considerations ............................................................................... 53 Human Papillomavirus Infection ..................................................................... 53 Suzanne M. Hewitt, M.P.A. Genital Warts ............................................................................................. 53 Subclinical Genital HPV Infection (Without Exophytic Warts) ........................ 57 Managing Editor Cervical Cancer Screening for Women Who Attend STD Clinics or Have a History of STDs ............................................................................ 57 Rachel J. Wilson Recommendations ...................................................................................... 58 Special Considerations ............................................................................... 59 Project Editor Vaccine Preventable STDs .............................................................................. 59 Hepatitis A ................................................................................................. 59 Hepatitis B ................................................................................................. 61 Malbea A. Heilman Hepatitis C .................................................................................................... 64 Beverly J. Holland Sexual Activity ............................................................................................ 65 Diagnosis and Treatment ............................................................................ 65 Visual Information Specialists Prevention .................................................................................................. 65 Postexposure Follow-Up ............................................................................. 66 Proctitis, Proctocolitis, and Enteritis ................................................................. 66 Michele D. Renshaw Treatment .................................................................................................. 67 Follow-Up .................................................................................................. 67 Erica R. Shaver Management of Sex Partners ...................................................................... 67 Information Technology Specialists Ectoparasitic Infections ................................................................................... 67 Pediculosis Pubis ........................................................................................ 67 Scabies ...................................................................................................... 68 Sexual Assault and STDs ...............................................................................
Recommended publications
  • Giardia Intestinalis, Also Known As G
    For Vets General Information Giardiosis is a disease caused by the protozoan parasite Giardia intestinalis, also known as G. duodenalis or G. lamblia. It is the most commonly identified pathogen in outbreaks of waterborne human disease in the USA. Clinical disease typically manifests as diarrhea. By far the most common source of infection for people is surface water contaminated by human fecal material. Within G. intestinalis there are a number of genotypes which are grouped into “assemblages” A to F. Assemblages A and B are capable of infecting several animal species, as well as humans. Other assemblages occur only in animals. Giardia, including zoonotic and species-specific assemblages, occurs frequently in dogs, and less commonly in cats, but the parasite can infect many species including beavers, livestock, ferrets, guinea pigs, gerbils, rats and chinchillas. The risk of zoonotic transmission of Giardia from pets remains controversial and unquantified, but the potential certainly exists. It is therefore important to be aware of the potential risk and encourage pet owners and people who handle animals to take steps to help prevent the spread of Giardia. Prevalence and Risk Factors Humans Giardiosis is endemic worldwide. In industrialized countries the prevalence of Giardia in people is estimated to be between 1-7%, but it may be as high as 50% in developing countries. All age groups are equally affected during epidemics, but both subclinical infection and clinical disease are more common in children in endemic areas. Outbreaks occur regularly in childcare facilities. Immunocompromised individuals are also more commonly affected than members of the general population.
    [Show full text]
  • MMWR Early and Were Reported to Two Respective Local Health Jurisdictions, Release on the MMWR Website (
    Morbidity and Mortality Weekly Report High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice — Skagit County, Washington, March 2020 Lea Hamner, MPH1; Polly Dubbel, MPH1; Ian Capron1; Andy Ross, MPH1; Amber Jordan, MPH1; Jaxon Lee, MPH1; Joanne Lynn1; Amelia Ball1; Simranjit Narwal, MSc1; Sam Russell1; Dale Patrick1; Howard Leibrand, MD1 On May 12, 2020, this report was posted as an MMWR Early and were reported to two respective local health jurisdictions, Release on the MMWR website (https://www.cdc.gov/mmwr). without indication of a common source of exposure. On On March 17, 2020, a member of a Skagit County, March 17, the choir director sent a second e-mail stating that Washington, choir informed Skagit County Public Health 24 members reported that they had developed influenza-like (SCPH) that several members of the 122-member choir had symptoms since March 11, and at least one had received test become ill. Three persons, two from Skagit County and one results positive for SARS-CoV-2. The email emphasized the from another area, had test results positive for SARS-CoV-2, importance of social distancing and awareness of symptoms the virus that causes coronavirus disease 2019 (COVID-19). suggestive of COVID-19. These two emails led many members Another 25 persons had compatible symptoms. SCPH to self-isolate or quarantine before a delegated member of the obtained the choir’s member list and began an investigation on choir notified SCPH on March 17. March 18. Among 61 persons who attended a March 10 choir All 122 members were interviewed by telephone either practice at which one person was known to be symptomatic, during initial investigation of the cluster (March 18–20; 53 cases were identified, including 33 confirmed and 20 115 members) or a follow-up interview (April 7–10; 117); most probable cases (secondary attack rates of 53.3% among con- persons participated in both interviews.
    [Show full text]
  • Potential Biomarkers As an Indicator of Vertical Transmission of Johne's
    Original Article J Vet Sci 2017, 18(S1), 343-349ㆍhttps://doi.org/10.4142/jvs.2017.18.S1.343 JVS Potential biomarkers as an indicator of vertical transmission of Johne’s disease in a Korean native cattle farm Hong-Tae Park1,†, Hyun-Eui Park1,†, Yong-Il Cho2, Eui-Hyung Kim3, Myunghwan Jung1, Seung Won Shin1, Su-Hyung Lee4, Dae-Yong Kim4, Han Sang Yoo1,* Departments of 1Infectious Diseases and 4Veterinary Pathology, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea 2Department of Animal Science & Technology, Suncheon National University, Suncheon 57922, Korea 3National Institute of Animal Science, Rural Development Administration, Pyeongchang 25340, Korea Paratuberculosis (PTB) is caused by Mycobacterium avium subsp. paratuberculosis (MAP) and is one of the most widespread and economically important diseases in cattle. After birth, calves are raised with natural breast feeding without separation from their mothers in most Korean native cattle (Hanwoo breed) farms. Vertical transmission of PTB has been reported, but the exact PTB infection route has not been revealed in Hanwoo farms. Calves of MAP seropositive dams were tested for MAP presence and MAP antibodies in feces and tissues. MAP was detected in calf tissues by using polymerase chain reaction. Expressions of genes reported to be prognostic biomarkers of MAP infection changed in both calves and cows (p < 0.05). Expression of two genes (HGF and SERPINE1) were significantly decreased in MAP-infected cattle and their offspring (p < 0.01). The results suggest that biomarker gene expression profiles can be useful in detecting early stage MAP infection. Based on the results, complete eradication of MAP may be possible if accurate diagnostic methods to detect infected calves are added to the current PTB eradication strategy, which, because infected individuals are likely to develop into fecal MAP shedders at any time, includes isolation of new born calves and feeding sterilized colostrum.
    [Show full text]
  • Asymptomatic Subclinical Cases of Coronavirus Disease 2019 Without Viral Transmission in Three Independent Families
    Infection and Drug Resistance Dovepress open access to scientific and medical research Open Access Full Text Article SHORT REPORT Asymptomatic Subclinical Cases of Coronavirus Disease 2019 without Viral Transmission in Three Independent Families This article was published in the following Dove Press journal: Infection and Drug Resistance Xian Zhang1,* Purpose: There is increasing evidence indicating that considerable fractions of cases of Liting Chen2,* SARS-CoV-2 infection are asymptomatic. We traced three asymptomatic clusters to inves­ Jia Wei2 tigate the infectivity of subclinical cases of coronavirus disease 2019 (COVID-19). Jianfeng Zhou2 Patients and Methods: Three medical staff who were asymptomatic were diagnosed with Yang Cao2 coronavirus disease 2019 by serological tests. Their close contacts were systematically evaluated based on COVID-19-related symptoms, nucleic acid tests, serological tests, and Gaoxiang Wang2 chest computed tomography (CT) as needed to determine if they were infected by SARS- 1Department of Ophthalmology, Tongji CoV-2. Hospital, Tongji Medical College, Huazhong University of Science and Results: None of the staff’s close contacts, including 10 family members, were infected by Technology, Wuhan, Hubei 430030, the indexes, even though no protective measures were taken. 2 People’s Republic of China; Department Conclusion: The infectivity of asymptomatic subclinical infection patients of coronavirus of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of disease 2019 seems to be low. Science and Technology, Wuhan, Hubei Keywords: SARS-CoV-2, COVID-19, asymptomatic, close contact, infectivity 430030, People’s Republic of China *These authors contributed equally to this work Introduction Toward the end of 2019, there was an outbreak of severe acute respiratory syn­ drome coronavirus 2 (SARS-CoV-2).
    [Show full text]
  • Subclinical Avian Influenza A(H5N1) Virus Infection in Human, Vietnam
    DISPATCHES leading to hospital admission. Despite intensive care and Subclinical Avian treatment with oseltamivir and antibiotics, the disease pro- gressed, and he died 2 days later. Influenza A(H5N1) A throat swab taken from the index case-patient on day 3 of illness was tested by reverse transcription PCR, and Virus Infection in results were positive for influenza A(H5N1) virus. Hemag- Human, Vietnam glutination inhibition (HI) and microneutralization (MN) tests for H5N1-specific antibodies were negative in sam- Mai Quynh Le, Peter Horby, Annette Fox, ples taken during the acute phase of illness (online Techni- Hien Tran Nguyen, Hang Khanh Le Nguyen, cal Appendix, wwwnc.cdc.gov/EID/article/19/10/13-0730- Phuong Mai Vu Hoang, Khanh Cong Nguyen, Techapp1.pdf). Menno D. de Jong, Rienk E. Jeeninga, On day 5 of illness of the index case-patient, a contact H. Rogier van Doorn, Jeremy Farrar, investigation was initiated. Throat swab specimens were and Heiman F.L. Wertheim collected from 4 household members and 1 close contact of the index case-patient: his spouse (age 47 years), daughter Laboratory-confirmed cases of subclinical infection (age 18 years), daughter-in-law (age 25 years), and grand- with avian influenza A(H5N1) virus in humans are rare, and son (age 1 year) and an unrelated man (age 43 years). None the true number of these cases is unknown. We describe of the contacts had signs or symptoms. Infection control the identification of a laboratory-confirmed subclinical case measures were initiated, and all household members were in a woman during an influenza A(H5N1) contact investiga- tion in northern Vietnam.
    [Show full text]
  • Management of Water-Related Microbial Diseases
    Management of Water-related Microbial Diseases First Edition 2003 The Department of Water U Affairs and Forestry Tl I75/DJ Water Research Commission REPORTS IN THIS SERIES This guide forms part of a series which is aimed at water supply agencies, water resource managers, workers in health-related fields, as well as communities throughout South Africa. The guide is intended to provide awareness-building information to keep water supplies clean of microbial contamination and thus reduce the incidence of water-related diseases. The publication of this report emanates from a WRC consultancy no 431: Guide on water-related microbiological diseases. The following documents form part of this series of Guides on the Management of Water-related Microbial Diseases: Vol: 1 What is the problem? - Disease Characteristics. Vol: 2 What causes the problem;1 - A What to Do for Water Suppliers following Diarrhoea Incidents. ' Vol: 3 How great is the problem? - Health Impact Assessment.1 Vol: 4 How dangerous is the problem? - Communicating the Risk.' Vol: 5 What we and our children need to know - Health & Hygiene Awareness.1 Still in preparation. This guide is available from: Director: Institute for Water Quality Studies Water Research Commission Department of Water Affairs & Forestry Private Bag X03 Private Bag X313 Geztna Pretoria 0031 0001 South Africa Tel: 012 808 0374 Tel: 012 330 0340 Fax: 012 808 0338 Fax: 012 331 2565 Disclaimer This report has been reviewed by the Water Research Commission (WRC) and approved for 1 publication. Approval does not signify that the contents necessarily reflect the views and policies of the WRC, nor does mention of trade names or commercial products constitute endorsement or f recommendation for use.
    [Show full text]
  • STD (Sexually Transmitted Disease) Or STI (Sexually Transmitted Infection): Should We Choose? Janet Byron Anderson, Phd
    STD (sexually transmitted disease) or STI (sexually transmitted infection): Should we choose? Janet Byron Anderson, PhD 1. Clinical foundation of the problem Another surprise: Documented incidence had shown Each of the terms—“sexual(ly)”, “transmitted”, “disease”, that the two routes of sexual transmission were male-to- and “infection”—is problematic independently, as this female and male-to-male. However, on 15 July 2016 the study will show. Moreover, co-occurring variants, used CDC reported the first case of suspected female-to-male as synonyms in English medical articles worldwide, ag- sexual transmission in New York City [4]. Since 2008, gravate the problem. The purpose of this study is to pro- then, the Zika virus has shown that it is now sexually pose a single term that can stimulate discussion about transmissible. “Transmissible” denotes a potential, and is whether the co-occurring variants are clinically and lin- distinct from “transmitted”, which denotes a reality. guistically justifiable—especially now, when STDs/STIs To say that Zika has proved to be transmissible through have become a global health problem, and public health sexual contact means that it can be transmitted through agencies in every country are scrambling to educate their sex but that it need not be (Zika remains a chiefly vec- citizens. [Until the presentation advances to the point tor-borne disease). However, cases reported since 2008 where the question posed in the title can be definitively document the reality of transmittedness through sexual answered, I’ll use the expression “STD/STI” or the terms contact. “illness(es)” and “condition(s)”.] The predisposing epidemiologic context will first be clar- This carefully differentiated language is used by the ified, for it sheds light on two of the problematic terms: European Centre for Disease Prevention and Control chiefly “transmitted” but also “sexual(ly)”.
    [Show full text]
  • Epidemiology of and Risk Factors for COVID-19 Infection Among Health Care Workers: a Multi-Centre Comparative Study
    International Journal of Environmental Research and Public Health Article Epidemiology of and Risk Factors for COVID-19 Infection among Health Care Workers: A Multi-Centre Comparative Study Jia-Te Wei 1, Zhi-Dong Liu 1, Zheng-Wei Fan 2, Lin Zhao 1,* and Wu-Chun Cao 1,2,* 1 Institute of EcoHealth, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China; [email protected] (J.-T.W.); [email protected] (Z.-D.L.) 2 State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China; [email protected] * Correspondence: [email protected] (L.Z.); [email protected] (W.-C.C.) Received: 31 August 2020; Accepted: 28 September 2020; Published: 29 September 2020 Abstract: Healthcare workers (HCWs) worldwide are putting themselves at high risks of coronavirus disease 2019 (COVID-19) by treating a large number of patients while lacking protective equipment. We aim to provide a scientific basis for preventing and controlling the COVID-19 infection among HCWs. We used data on COVID-19 cases in the city of Wuhan to compare epidemiological characteristics between HCWs and non-HCWs and explored the risk factors for infection and deterioration among HCWs based on hospital settings. The attack rate (AR) of HCWs in the hospital can reach up to 11.9% in Wuhan. The time interval from symptom onset to diagnosis in HCWs and non-HCWs dropped rapidly over time. From mid-January, the median time interval of HCW cases was significantly shorter than in non-HCW cases.
    [Show full text]
  • The Cursed Duet Today: TB and HIV-Coinfection
    The cursed duet today: TB and HIV-coinfection Simon Tiberi#1, Anna Cristina C. Carvalho#2, Giorgia Sulis#3, Devan Vaghela#4, Adrian Rendon5, Fernanda C de Q Mello6, Ananna Rahman7, Nashaba Matin8, Alimuddin Zumla9, Emanuele Pontali10 # contributed equally Address of Correspondence: Division of Infection, Royal London Hospital, Barts Health NHS Trust. 80 Newark St. London E1 2ES, United Kingdom. Email: [email protected], Tel: +44 745001158 Affiliations 1. Division of Infection, Royal London Hospital, Barts Health NHS Trust, 80 Newark Street London E1 2ES, United Kingdom. Email: [email protected] 2. Laboratory of Innovations in Therapies, Education and Bioproducts, (LITEB), Oswaldo Cruz Institute (IOC), Fiocruz, Rio de Janeiro, Brazil. Email: [email protected] 3. University Department of Infectious and Tropical Diseases, World Health Organization Collaborating Centre for TB/HIV co-infection and TB elimination, University of Brescia, Brescia, Italy. Email: [email protected] 4. Department of Respiratory Medicine, Royal London Hospital, Barts Health NHS Trust, 80 Newark Street London E1 2ES, United Kingdom. Email: [email protected] 5. Centro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias, Hospital Universitario de Monterrey, Monterrey, Nuevo León UANL, México. Email: [email protected] 6. Instituto de Doenças do Tórax (IDT)/Clementino Fraga Filho Hospital (CFFH), Federal University of Rio de Janeiro, Rua Professor Rodolpho Paulo Rocco, n° 255 - 1° Andar - Cidade Universitária - Ilha do Fundão, 21941-913, Rio De Janeiro, Brazil. Email: [email protected] 7. Department of Respiratory Medicine. Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridge, United Kingdom. Email: [email protected] 8.
    [Show full text]
  • Arxiv:1705.01135V2 [Q-Bio.QM] 17 Jul 2020 Author Summary
    Estimating and interpreting secondary attack risk: Binomial considered harmful Yushuf Sharker1, Eben Kenah2, * 1 Division of Biometrics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA 2 Biostatistics Division, College of Public Health, The Ohio State University, Columbus, Ohio, USA * [email protected] Abstract The household secondary attack risk (SAR), often called the secondary attack rate or secondary infection risk, is the probability of infectious contact from an infectious household member A to a given household member B, where we define infectious contact to be a contact sufficient to infect B if he or she is susceptible. Estimation of the SAR is an important part of understanding and controlling the transmission of infectious diseases. In practice, it is most often estimated using binomial models such as logistic regression, which implicitly attribute all secondary infections in a household to the primary case. In the simplest case, the number of secondary infections in a household with m susceptibles and a single primary case is modeled as a binomial(m; p) random variable where p is the SAR. Although it has long been understood that transmission within households is not binomial, it is thought that multiple generations of transmission can be safely neglected when p is small. We use probability generating functions and simulations to show that this is a mistake. The proportion of susceptible household members infected can be substantially larger than the SAR even when p is small. As a result, binomial estimates of the SAR are biased upward and their confidence intervals have poor coverage probabilities even if adjusted for clustering.
    [Show full text]
  • Colonization V. Infection
    Colonization vs Infection Colonization • The presence of microorganisms in or on a host with growth and multiplication but without tissue invasion or damage • Understanding this concept is essential in the planning and implantation of epidemiological studies in a healthcare infection prevention and control program Infection v. Colonization • Confusing colonization with infection can lead to spurious associations that may lead to expensive, ineffective, and time‐ consuming interventions Multi Drug‐Resistant Organisms Management in Long Term Care • Colonization may become infection when changes in the host Facilities Workshop occur Louisiana Office of Public Health Healthcare‐Associated Infections Program Objectives Colonization: Definition By the end of the presentation, attendees will be able to: • Colonization: presence of a microorganism on/in a host, with • Define colonization growth and multiplication of the organism, but without • Differentiate colonization from infections interaction between host and organism (no clinical expression, no immune response). • Apply appropriate laboratory test by common LTC infectious • agents Carrier: individual which is colonized + more • • Understand the necessity of communicating infectious status Subclinical or unapparent infection: presence of upon patient transfer microorganism and interaction between host and microorganism (sub clinical response, immune response). Often the term colonization is applied for relationship host‐ agent in which the immune response is difficult to elicit. • Contamination: Presence of a microorganism on a body surface or an inanimate object. 1 Colonization vs Infection Spectrum: No Exposure ‐ Exposure ‐ Colonization ‐ Carrier Infection ‐ Disease A carrier is an individual that harbors a specific microorganism Host + Infectious agent What is “Exposed” ? in the absence of discernible clinical disease and serve as a No foothold: Exposed Means of transmission: potential source of infection.
    [Show full text]
  • Cohort Studies for Outbreak Investigations
    VOLUME 3, ISSUE 1 Cohort Studies for Outbreak Investigations In a previous issue of FOCUS, we To be certain that an exposure caused introduced cohort studies and talked the disease, the unexposed group CONTRIBUTORS about how to decide whether a co- must be similar to the exposed group hort study is the best design for your in all respects except the exposure. Author: situation. Remember that cohort Therefore they should have similar Amy Nelson, PhD, MPH studies are useful when there is a demographic characteristics such as defined population at risk for devel- age, gender, race, and income. If you Kim Brunette, MPH oping the disease of interest (such compare an “unexposed” elementary FOCUS Workgroup* as all members of the Glee Club) and school to an “exposed” elementary when it is possible to interview all school, both schools should be lo- Reviewers: members or a representative sample cated in neighborhoods with the same FOCUS Workgroup* of the cohort. types of economic and other opportu- nities, similar socio-economic status Production Editors: In outbreak investigations, cohort (SES), similar parent involvement, Tara P. Rybka, MPH studies are usually retrospective similar school resources, and similar Lorraine Alexander, DrPH because in an outbreak an exposure has already occurred, and enough student populations. Gloria C. Mejia, DDS, MPH cases to signal an outbreak have Using groups that have other differ- Editor in chief: also occurred. The aim is to deter- ences may lead to “confounding.” If Pia D.M. MacDonald, PhD, MPH mine what exposures occurred in the you compare a low-income public past to cause these cases of dis- school to a private boarding school, ease.
    [Show full text]